Those opposing marijuana have been coming forward to warn about the possible negative effects of marijuana use now that people are learning more about the medicinal values of the plant. Many medical marijuana patients report their debilitating symptoms, such as chronic pain or nausea, as being successfully treatable with marijuana. This could be a threat to large pharmaceutical companies that generate huge amounts of revenue from the sale of prescription drugs designed to treat the same symptoms, such as pain, nausea and many others. Could these large pharmaceutical manufacturers be funding the voices of medical marijuana opposition?
One medical marijuana opponent is Dr. Herbert Kleber, professor of psychiatry at Columbia University. Dr. Kleber is, also, Director of the Division on Substance Abuse for New York State Psychiatric Institute, and has worked as a consultant for companies that are the leading manufacturers of opioid drugs. He has also been contributing editor to studies funded by by the same companies. The recommendation made to the New York State Association of Chiefs of Police, in a study Dr. Kleber coauthored, was used against legalization in the state.
As Lee Fang pointed out, Dr. A Eden Evins of Harvard Medical and Dr. Mark Cross, board member to the American Society of Addiction Medicine, are also medical marijuana opponents that have worked with opiod manufacturers. Unfortunately, when these people speak publicly or write against medical marijuana, they neglect to disclose that they may have a conflict of interest in the matter. This may bring about mistrust in the word of even the most respected industry professionals and academic researchers who set precedence in the prescription world.
With medical marijuana out of the way, pharmaceutical companies could take over by creating synthetic versions of the medicinally valuable cannabinoids that occur naturally in the cannabis plant. The door would be open for Big Pharma to continue to rake in boat loads of money if the people have a negative outlook towards medical marijuana.
Can so many medical marijuana patients be wrong to say that marijuana provides relief from debilitating symptom? As CNN reported, opiod related deaths have decreased in the states that allow medical marijuana. Could this decrease have anything to do with patients seeking a more natural form of relief? Hopefully more information, from unbiased studies, will be presented on this topic in the near future.